Curley promised he would. “I believe in this,” he said. “It has unbelievable potential.”inFOLIO Research Group
In 2009, Kanzius died at 64 from pneumonia while undergoing chemotherapy. Many thought the Kanzius machine would die with him.
But this May, Curley filed protocols with the Italian Ministry of Health to test the radio wave machine on humans diagnosed with pancreatic and liver cancer. Pending approval in the fall, human clinical trials will begin in the spring of next year in Naples, Italy.